|
|
|
|
 |
|||
|
|||
Volume 53 (2): 141-153, 2005
Copyright ©The Histochemical Society, Inc.
REVIEW |
Zinc-specific Autometallographic In Vivo Selenium Methods : Tracing of Zinc-enriched (ZEN) Terminals, ZEN Pathways, and Pools of Zinc Ions in a Multitude of Other ZEN Cells
Department of Neurobiology, Institute of Anatomy, University of Aarhus, Aarhus C, Denmark
Correspondence to: Dr. Gorm Danscher, Department of Neurobiology, Institute of Anatomy, University of Aarhus, DK-8000 Aarhus C, Denmark. E-mail: gd{at}neuro.au.dk
 |
Summary |
|---|
 Top Summary IntroductionMaterials, Methods, and ResultsFuture Fields of Application...DiscussionLiterature Cited |
|---|
In vivo–applied sodium selenide or sodium selenite causes the appearance of zinc–selenium nanocrystals in places where free or loosely bound zinc ions are present. These nanocrystals can in turn be silver enhanced by autometallographic (AMG) development. The selenium method was introduced in 1982 as a tool for zinc-ion tracing, e.g., in vesicular compartments such as synaptic vesicles of zinc-enriched (ZEN) terminals in the central nervous system, and for visualization of zinc ions in ZEN secretory vesicles of, e.g., somatotrophic cells in the pituitary, zymogene granules in pancreatic acinar cells, beta-cells of the islets of Langerhans, Paneth cells of the crypts of Lieberkühn, secretory cells of the tubuloacinar glands of prostate, epithelium of parts of ductus epididymidis, and osteoblasts. If sodium selenide/selenite is injected into brain, spinal cord, spinal nerves containing sympathetic axons, or intraperitoneally, retrograde axonal transport of zinc–selenium nanocrystals takes place in ZEN neurons, resulting in accumulation of zinc–selenium nanocrystals in lysosomes of the neuronal somata. The technique is, therefore, also a highly specific tool for tracing ZEN pathways. The present review includes an update of the 1982 paper and presents evidence that only zinc ions are traced with the AMG selenium techniques if the protocols are followed to the letter. (J Histochem Cytochem 53:141–153, 2005)
Key Words: selenium • autometallography • AMG • nanocrystals • zinc ions • vesicles • zinc-enriched • ZEN
|
Introduction |
|---|
|
TopSummaryIntroductionMaterials, Methods, and ResultsFuture Fields of Application...DiscussionLiterature Cited |
|---|
THE PRESENCE OF ZINC IONS in a subpopulation of synaptic vesicles of a rather numerous group of glutaminergic neurons in the brain and GABAergic, glutaminergic, and possibly glycinergic neurons in the spinal cord and cerebellum, the so-called zinc-enriched (ZEN) neurons, is well established (Slomianka 1992
; Danscher et al. 1997,2001; Rubio and Juiz, 1998; Sensi et al. 1999; Frederickson et al. 2000; Jo et al. 2000a; Schrøder et al. 2000; Weiss et al. 2000; Birinyi et al. 2001; Wang et al. 2001a,b,2002a,b; Miro-Bernie et al. 2003). Recently, we have found populations of sympathetic neuronal somata having the hallmarks of ZEN neurons in the superior cervical and lumbar ganglia of rodents (Wang et al. 2002a,2003). Both inhibitory and excitatory ZEN terminals in the central nervous system and the ZEN candidate neuronal somata of lumbar and superior cervical ganglia have been shown to contain a pool of vesicles with zinc transporter proteins (ZnT3) in their membranes (Palmiter et al. 1996; Cole et al. 1999; Danscher et al. 2001; Wang et al. 2001b,2002b,2003).
In addition to zinc ions found in ZEN neurons, zinc ions are known to exist in secretory vesicles of a number of exo- and endocrine glands, including testis, epididymis, prostate, pancreas, male mouse salivary glands, pituitary, and intestine, and extracellularly in uncalcified bone and semen (Danscher 1982; Danscher et al. 1985a,1999; Thorlacius-Ussing et al. 1985; Frederickson et al. 1987a; Stoltenberg et al. 1996,1997; Sørensen et al. 1997,1998; Kristiansen et al. 2001).
The NeoTimm method was introduced in 1981. This zinc ion–specific version of Timm's original sulfide silver method (Timm 1958) evolved from two Timm modifications (Haug 1974; Danscher and Zimmer 1978). Timm's technique involves the creation of zinc–sulfur nanocrystals, and the NeoTimm method includes transcardial perfusion or intravenous (IV) injections in deeply anesthetized animals with a sodium sulfide solution or immersion of tissue blocks, slides, or sections in a solution of glutaraldehyde and sodium sulfide (Danscher 1981; Danscher et al. 2004). To ensure that the NeoTimm method demonstrates only zinc ions, the amount of sodium sulfide molecules has to match the amount of zinc ions in the tissues. The right amount has been defined as the highest level of sulfide ions that does not cause staining of sections from an animal exposed to 1000 mg/kg body weight of the zinc chelator diethyldithiocarbamate (DEDTC) 1 hr before perfusion (Danscher et al. 1973; Danscher 1981). In vivo chelation with the red chelator dithizone likewise results in a lack of Timm staining (Danscher et al. 1985b). Tissue sections from animals that have been perfused with sodium sulfide according to the NeoTimm method or treated in vivo with sodium selenide/selenite cannot be stained with the fluorescence techniques TSQ and Zinquin, which proves that it is the same pool of zinc that is stained with the different zinc-specific methods (Danscher 1981,1982; Danscher et al. 1985b; Frederickson et al. 1987b; Zalewski et al. 1993).
The selenium technique involves, as mentioned above, in vivo injections of sodium selenite/selenide and is presently the only available way of capturing zinc ions in vivo for subsequent tracing of zinc–selenium nanocrystals in tissue sections by autometallographic (AMG) silver enhancement. Another valuable quality of the technique is that zinc–selenium nanocrystals are more resistant to weak acids than are the zinc–sulfur nanocrystals, the silver-enhanceable entities of the NeoTimm methods (Danscher 1981,1996; Stoltenberg and Danscher 2000; Danscher et al. 2004). This relative pH stability of the zinc–selenium nanocrystals is also the quality that makes it possible to trace the neuronal somata of ZEN neurons. Nanocrystals of zinc–selenium created in the ZEN terminals and/or in the ZEN axons after, e.g., a local injection with sodium selenide, accumulate in lysosomes of the ZEN neuronal somata after having been translocated by retrograde axonal transport (Danscher 1982; Howell and Frederickson 1990; Christensen et al. 1992).
We did not find AMG grains in the lysosomes of animals injected intracerebrally (IC) with sodium sulfide, but only in a pool of synaptic vesicles in the ZEN terminals and their synaptic clefts. The AMG silver grains resulting from such IC injections are released into the synaptic clefts over the following 24–48 hr (Danscher 1984b; Pérez-Clausell and Danscher 1986). We have hypothesized, therefore, that due to the low pH in the lysosomes, retrogradely transported zinc–sulfur nanocrystals are dissolved while zinc–selenium nanocrystals are left intact for a period of time (Danscher 1994). Thus, the zinc–selenium autometallography (ZnSeAMG) technique for tracing ZEN neuronal pathways involves systemic or intraperitoneal (IP) injections of sodium selenite/selenide into brain and spinal cord and survival times that allow the zinc nanocrystals to be transported along the ZEN axons and deposited in lysosomes in the ZEN neuronal somata (Danscher 1982,1984b,1994; Howell and Frederickson 1990; Slomianka et al. 1990; Christensen et al. 1992; Wang et al. 2001a; Brown and Dyck 2003).
Selenium is the third member of the sixth group of the periodic system, next to sulfur. The chemistry of these two elements is in many respects quite similar, but they also differ considerably due to differences in ionic volume and electron negativity.
Sodium selenite was the first selenium compound used to create zinc–selenium nanocrystals in living organisms (Danscher 1982). It is a rather toxic substance, and experimental animals can show signs of lung edema after IP injections and demonstrate considerable lesions after IC injections. Therefore, sodium selenite exposure should always be performed on anesthetized animals and be followed by pain-killing drugs like buprenorphin when longer survival times are needed. The best possible selenide ion donator for IC injections has been found to be sodium selenide (Christensen et al. 1992). The synthesis of this drug is laborious in a standard laboratory but, fortunately, sodium selenide is now commercially available (Alfa 36187; Zeppelinstrasse 7, Karlsruhe, Germany).
The aim of the present study was to present updated, optimal, and easy-to-apply protocols for light- and electron-microscopy ZnSeAMG. The possibility of using the technique in mapping the biological and toxicological aspects of selenium compounds is mentioned in the Discussion.
|
Materials, Methods, and Results |
|---|
|
TopSummaryIntroductionMaterials, Methods, and ResultsFuture Fields of Application...DiscussionLiterature Cited |
|---|
It is recommended that animals undergoing ZnSeAMG be anesthetized with ketaminol and narcoxyl and that Temgesic (buprenorphin) be used as an analgeticum when the selenium-exposed animals must survive the initial anesthesia.
Tracing of ZEN Terminals by IP Injections of Sodium Selenite
Tissue sections containing ZEN cells from animals given selenium under anesthesia and sacrificed after 1–2 hr demonstrate an AMG staining of zinc–selenium nanocrystals located in different types of ZEN vesicles (Figures 1 and 2
, Figures 3a and 3c , Figure 4c)
.
|
|
|
|
Sodium selenite is a good choice for systemic creation of zinc–selenium nanocrystals. However, in some cases an IP or IV injection of sodium selenide might prove a better solution.
Tracing of ZEN Pathways by IC Injections of Sodium Selenide
Tracing of ZEN neuronal somata takes place by IP or IC injections of sodium selenide. The IC injections can be performed either by electrophoreses or by pressure injection of selenide ions. If the IP-injected selenide is used for tracing ZEN neuronal somata in the brain, it is important that the dose of sodium selenide used is high enough to ensure that all ZEN somata are loaded (Slomianka et al. 1990). The IP technique has, e.g., proven to be unsuccessful for tracing ZEN somata in the spinal cord, most likely because a sufficient level of selenium-loaded ZEN terminals cannot be achieved.
After 24 hr, some ZEN terminal staining will continue to be visible in the brain, in particular if the IC technique is used. This staining results from synaptic vesicles that have not yet released their content of zinc–selenium nanocrystals into the synaptic cleft or have been transported to the ZEN somata by retrograde axonal transport (Figure 4d) and can be seen up to 48 hr after injection. Nevertheless, the retrogradely stained ZEN somata are distinct (Figures 4a and 4b). Terminal staining can be reduced by pre-incubation with H2O2. Although this technique, of course, reduces the overall staining, it might be useful for preparing clear low-magnification photographs of the ZEN somata (Brown and Dyck 2003).
Tracing of Zinc Ion Pools in Exo- and Endocrine Secretory Cells
The finding of zinc–selenium nanocrystals in secretory vesicles of secretory cells of both the exocrine and the endocrine pancreas, as well as mast cells (Figure 4e), liver (Figure 4f), intestine, and many more locations, indicates that vesicular zinc ions, transported into the vesicular vacuum by specialized transmembrane transporting molecules (e.g., ZnT3), must have a more general function in the secretory and synaptic vesicles. It is also characteristic that it is always only a fraction of the vesicles in a certain secretory cell or neuronal terminal that contain zinc ions. Whether this reveals a difference in maturity of the vesicles or reflects the presence of more than one type of secretory/synaptic vesicle is not known at present. It might be reasonable to term cells with zinc ion-containing vesicles Zinc ENriched (ZEN) cells, inasmuch as they may have a basic biological mechanism in common.
Optimal and Easy-to-apply Protocols for ZnSeAMG
Sectioning of Tissue
Tissue blocks from selenium-exposed animals that have been transcardially perfused with a fixative, e.g., a glutaraldehyde or paraformaldehyde solution in 0.1 M phosphate buffer, for 15 min are post-fixed for 2 hr in the fixative. We have found that post-fixation in the above fixatives for >6 hr reduces the quality of the AMG staining.
Cryostat Sections
Tissue blocks are submersed in a 30% sucrose solution until they sink to the bottom of the vial, frozen with CO2 gas, and cut into 30-µm-thick sections on a cryostat. Non-fixed tissue can be frozen directly without prior exposure to sucrose. The sections are then placed on 10% Farmer-cleaned glass slides and, if not processed immediately, stored at –17C (and can be kept in this way for several months). The AMG staining process is initiated by fixing the sections in 90% ethanol, rehydrating them, and covering them with gelatin by dipping them in 0.5% gelatin (Art. 4078; Merck, Albertslund, Denmark). After drying, the cryostat sections are ready for AMG development (described below) (Figure 5)
.
|
Vibratome Sections
Tissue blocks from perfusion-fixed organs are placed in a vibratome, and 100-µm sections are cut. The sections are then developed floating in the AMG developer. For further details, see also Danscher (1996)
.
ZEN Terminal Tracing by In Vivo Exposure to Sodium Selenite
Animals are anesthetized with ketaminol and narcoxyl and injected with 20 mg sodium selenite per kg bodyweight. Temgesic (buprenorphin) is used as an analgeticum. After 1 1/2 to 2 hr, the animals are either decapitated, the brains taken out, placed on a freeze stand, and cut in a cryostat, or the animals are transcardially perfused with buffered glutaraldehyde for 10 min and the brains placed in the fixative for 2 hr. The brains are then processed for either cryostat, paraffin, or vibratome sectioning.
ZEN Terminal Tracing by In Vivo Exposure to Sodium Selenide
All animal procedures are the same as above for sodium selenite, except for IP injections of 15 mg sodium selenide per kg bodyweight.
Tracing of ZEN Pathways by Local or Systemic Injections of Sodium Selenide
Before injection, the animals are deeply anesthetized with ketaminol and narcoxyl. Temgesic is used as an analgeticum. The animals are then placed in a stereotaxic apparatus, the calvarium is freed, and holes are drilled with a dentist's drill. Injections of 1 µl of a 10 mg/ml freshly made sodium selenide are performed with a Hamilton syringe (injection volume can vary between, e.g., 0.02 and 10 µl) over a period of 10 min. The syringe is left in situ for 2 min after the injection.
Alternatively, the selenium is applied iontophoretically with a micropipette. An intermittent current of 4 µA (tip negative) is applied for a total of 20–30 sec over a period of 5 min. The micropipette is left in situ for an additional 5 min after the injection (Christensen et al. 1992). After 1- to 48-hr survival, depending on the length of the ZEN pathways and type of animal used, the animals are re-anesthetized and either decapitated or perfused transcardially with a fixative as described above.
Brains from the decapitated animals are frozen with CO2. Brains from the perfused animals are kept in the fixative for at least 1 hr and then either vibratomized to be processed for Epon embedding, placed in sucrose, and cut on a cryostat or embedded in paraffin, vide supra.
Tracing of Zinc Ions in Non-neuronal Tissues (e.g., Testis, Salivary Gland, Pancreas, Prostate, Epididymis, Small Intestine, Liver, Lung, Adrenal, Bone, Thyroid Gland, and Anterior Pituitary)
Sodium selenite/sodium selenide is injected IP into anesthetized animals. After 1 1/2- to 2-hr periods of survival, the animals are killed by transcardial perfusion with 3% glutaraldehyde in a 0.1 M phosphate buffer for 10 min. The organs/tissues of interest are removed and processed as described for the brain. If the organs are small or lack rigidity, it is advantageous to stabilize them by dripping agar onto the vibratome stage. A 5% agar solution is boiled for 10 min, and when the solution has cooled to 
40C, the solution is dripped onto the organ pieces, where it will solidify. Bones are sawed into 300-µm-thick sections that are dipped in a 0.5% gelatin solution and AMG developed. Small pieces of the developed bone sections are fixed in osmium and embedded in metacrylate or Epon. The vibratome sections are developed as described above.
It is possible to trace extracellular pools of zinc ions, e.g., in unmineralized bone matrix (Danscher et al. 1999), semen plasma, secretions in the prostate secretory system, ductus epididymidis, and crypts of Lieberkühn. Zinc ions in such locations are found by exposing the organisms to sodium selenite or sodium selenide in vivo as described above.
Zinc Specificity of the ZnSeAMG Technique
- IP injections of 150 mg dithizone per kg bodyweight 4 hr before sodium selenide exposure result in a complete block of the ZnSeAMG staining in brain sections (see also Danscher 1982,1984a,1984b,1984c).
- IP injections of 1000 mg DEDTC 1 hr before selenium treatment result in unstained brain sections (see also Danscher et al. 1973; Danscher 1982,1984a).
- Local injections of DEDTC in rat brain followed by IP injections of sodium selenite after the normal ZnSeAMG procedure result in a spherical, totally unstained "hole" in the staining pattern, revealing where the zinc ions have chemically bound to the chelating DEDTC molecules and thereby been made inaccessible to the selenide ions (Danscher 1984b).
- It was not possible to stain brain sections from animals treated with sodium selenite IP 1 1/2 hr before sacrifice with either of the fluorescence stains TSQ or Zinquin.
- Brains from ZnT3 mice show no ZnSeAMG staining of ZEN terminals in mouse brain (Stoltenberg et al. unpublished data).
- The ZnSeAMG staining patterns of mouse brain, spinal cord, and olfactory bulb are identical to the ZnT3 immunohistochemical staining patterns of the same localities (e.g., Jo et al. 2000b).
- Synaptic ZEN vesicles of both glutaminergic and GABAergic ZEN terminals contain ZnT3 proteins in their vesicular membrane.
- Multi-element (PIXE) analysis of isolated ZnSeAMG grains shows the presence of silver and selenium, while the same analysis on isolated ZnSAMG grains shows that these grains contain silver and sulfur. These results reveal that the zinc–selenium and zinc–sulfur nanocrystals are transformed into silver–selenium and silver–sulfur nanocrystals, respectively, in the initial phases of the autometallographic development (see also Danscher 1984a,1996).
|
Future Fields of Application of the ZnSeAMG Techniques |
|---|
|
TopSummaryIntroductionMaterials, Methods, and ResultsFuture Fields of Application...DiscussionLiterature Cited |
|---|
AMG Tracing of Zinc Ions in Cell Suspensions and Cell Cultures (e.g., Sperm Cells, Macrophages, and Blood) and Organotypic Cell Cultures
On the basis of unpublished results, we suggest that the cells in question can be exposed to sodium selenide or sodium selenite either in vivo or in vitro. After having been collected, the samples are concentrated by centrifugation. The resulting pellet/concentrated probe is then fixed (e.g., with glutaraldehyde (GA) or paraformaldehyde (PFA) and embedded in Epon. Another approach involves AMG development of the pellet before embedding in Epon. The AMG development is stopped by adding the AMG stop bath (a 5% thiosulfate solution), after which the cells are rinsed by adding distilled water and centrifuged several times; finally, the cells are fixed with osmium tetroxide, rinsed again as described above, and embedded in Epon. Another possibility is to make smears on glass slides of the cell suspensions/cultures and develop them as described above. Organotypic cultures are exposed to sodium selenide/selenite by adding it to the medium. The tissue is rinsed in a 0.1 M Sørensen phosphate buffer and fixed for 10 min in buffered GA, then rinsed again in distilled water, and AMG developed for, e.g., 60 min. After a rinse, the tissue is fixed in osmium tetroxide for 30 min, re-rinsed in distilled water, and embedded in Epon.
It is important to stress that these new applications demand individual adjustments and must be checked for zinc specificity with DEDTC or other non-toxic zinc chelators.
Can Other Selenium Compounds Give Rise to ZnSeAMG Staining?
Since the introduction of the selenium method (Danscher 1982), different selenium compounds, including selenocysteine and selenomethionine (O'Toole et al. 1995), have been tested to find the ideal selenium donator for the demonstration of ZEN terminals as well as retrograde axonal transport of zinc ions (Danscher 1984b,1994; Howell and Frederickson 1990; Christensen et al. 1992). The major disadvantage of most of the compounds previously investigated has been their rather high tissue toxicity, causing large tissue necrosis and, in some cases, even death.
We have tested many commercially available selenium compounds (e.g., selenocysteine and selenomethionine, selenium tetrachloride, sodium selenate, powdered selenium, and dimethyl selenium). They all result in a less-complete binding of the AMG traceable zinc pool, but the ZnSeAMG technique might, nevertheless, be an interesting tool for research in selenium metabolism and toxicity.
Selenourea releases molecular selenium after gentle intracranial injections, with no tissue destruction along the injection canal (Figure 3d). Selenourea injected in amounts of 1 µl causes the appearance of a 2-mm spherical spot of AMG staining around the needle tip. Selenourea is an organic compound with selenium in the center of the molecule. The same properties that make selenourea suitable for intracranial injections exclude its use for IP or IV injections, inasmuch as the decomposition to molecular selenium will take place long before the selenide ions reach the brain.
Selenosulfate was synthesized in our laboratory, and it was found that 38 µmol selenosulfate resulted in a staining pattern and intensity similar to that of sodium selenite (Figure 3b). Selenosulfate-based ZnSeAMG is a stable and reproducible technique that results in uniformly stained sections of high technical quality. However, since selenosulfate is not commercially available and demands some effort to produce, we recommend sodium selenide/selenite as the best choice.
AMG Development
A vast amount of different AMG developers have been suggested since Liesegang introduced physical development into histology (Liesegang 1911). Stierhof et al. (1991) carried out a test on the quality of some of the most commonly used AMG developers at the time for silver enhancement of colloidal gold particles. Any suitable AMG developer can be used to silver enhance the zinc–selenium nanocrystals, including the silver acetate AMG developer (Hacker et al. 1988). In our laboratory, we continue to obtain the best results with the silver lactate/hydroquinone/gum arabic mixture (Danscher 1981).
It is imperative that all glassware and tools used for AMG development be rinsed in a 10% Farmer solution (see above) and that high-purity, high-quality chemicals and redistilled water be used.
In daylight, the developer is poured into jars containing the slides. These are placed in a 26C shaking water bath in a dark box—without the dark box the developer will gradually turn brown because of the creation of tiny silver particles. The developing time for 20-µm cryosections is 60 min. Development is stopped by replacing the developer with 5% thiosulfate. After 10 min, the stop bath is removed, and the slides are rinsed in distilled water before being counterstained with, e.g., toluidine blue and coverslipped. One should always include one or more control glass slides among the experimental slides, i.e., glass slides with sections that give a well-known pattern of AMG staining, to ensure that the development has been optimal.
|
Discussion |
|---|
|
TopSummaryIntroductionMaterials, Methods, and ResultsFuture Fields of Application...DiscussionLiterature Cited |
|---|
Selenium seems to function in the body primarily as a catalyst and has been found to function as a prosthetic group of a variety of enzymes and to interact with tocopherol to protect membranes from oxidative damage and facilitate the union of oxygen and hydrogen (Frost and Lish 1975
). Selenium is also known to protect against the toxic effects of: (a) heavy metals, such as lead, cadmium, arsenic, and mercury; and (b) some organic toxicants in man and other mammals (Wilber 1980). The major selenium species in cereals and vegetables are selenomethionine and selenocysteine (Barceloux 1999), and it is now clear that selenium is essential to health and normal birth (Castillo-Duran and Cassorla 1999; Maiorino et al. 1999; Rayman and Rayman 2002).
The toxicity of most selenium compounds is rather low, but is dependant on the chemical form (Barceloux 1999). The US National Toxicology Program lists selenium sulfide as an animal carcinogen, but there are no results indicating other selenium compounds to be carcinogens (Barceloux 1999). However, from the thousands of articles on toxicity, it is obvious that the levels of sodium selenide/selenite used to create the pattern of zinc–selenium nanocrystals are very toxic to the animals. Therefore, it is imperative that the animals be anesthetized before being treated with the two selenium compounds, and that pain-killers be given if the animals must survive for periods that exceed the effect of the initial anesthesia.
The IC injection of sodium selenide results in little or no damage to brain tissue, while sodium selenite gives rise to substantial damage around the injection canal (Christensen et al. 1992; Danscher 1994; Christensen 1995; Christensen and Frederickson 1998). The selenite-caused lesions most likely are redox damage caused by the Se4+ being reduced to Se2– ions.
From the data obtained in the present study and from experience using the ZnSeAMG techniques for more than 20 years, it can be concluded that the two best selenium donors for in vivo binding of zinc ions in zinc–selenium nanocrystals are sodium selenide and sodium selenite (see also Christensen et al. 1992). The reason for this is, without any doubt, that only these two selenium compounds give rise to the necessary levels of selenide ions (Se2–) to cause the creation of zinc–selenide molecules that in turn accumulate in zinc–selenium nanocrystals.
A strange phenomenon is seen after IP injections of sodium selenite if the time of exposure is less than 1 1/2 to 2 hr. In such animals, the hilus fasciae dentatae and amygdala are not at all or only lightly stained. The reason for this is not completely understood, but we have hypothesized that it is partly the result of the fact that selenium has to be reduced from Se4+ to Se2– and that the number of zinc ions is particularly high in these areas, but also that local peculiar chemical conditions may play a role. The phenomenon vanishes after 1 1/2 to 2 hr of selenium exposure and is never seen after IC injections (see also Howell et al. 1989).
The functional roles of the ZnSeAMG-traceable zinc ions in the different cells are far from completely resolved. In pancreatic ß-cells it has been found that zinc ions in the secretory granules function as a kind of glue that makes the insulin molecules collect in hexameres (Derewenda et al. 1989; Dodson and Steiner 1998; Søndergaard et al. 2003). In this way, the peptide becomes osmotically "invisible." It could very well be that such a function of zinc ions in ZEN vesicles is the original one, i.e., the synaptic vesicles are equipped with transmembrane zinc ion transporters (ZnTs), causing the interior zinc ion pressure to increase, which then leads to an ordered packing of proteins or peptides in the vesicle. When a ZEN vesicle connects to the surface membrane and the vesicular space confluences with the extracellular space, zinc ions will pour out, leading to a release of protein/peptide from the packed form.
The next step in this process could be that the released zinc ions become involved in other processes. In pancreas, it has been suggested that the zinc ions process a paracrine function by inhibiting glucagon release from 
-cells (Kim et al. 2000; Ishihara et al. 2003), and in the brain, zinc ions released in glutaminergic synapses have been suggested to influence different post-synaptic receptor sites, such as NMDA and GABA receptors (Li et al. 2001; Hosie et al. 2003).
In conclusion, for zinc-ion tracing, we recommend in vivo treatment with sodium selenite or sodium selenide, depending on the purpose. Other selenium compounds tested all result in a less-sufficient creation of zinc–selenium nanocrystals at locations known to harbor loosely bound and free zinc ions. Nevertheless, the ZnSeAMG approach might be of interest for research on the metabolism and toxicity of selenium-containing compounds that give rise to in vivo creation of zinc–selenium nanocrystals.
As an additional note, other metal–selenium nanocrystals can be silver enhanced by AMG, i.e., silver–selenium, mercury–selenium, and bismuth–selenium nanocrystals created in organisms that have been exposed to the above heavy metals (see also Stoltenberg and Danscher 2000). No doubt, more AMG-traceable heavy metal–selenium nanocrystals will be introduced in the years to come, either because it is revealed that they are metabolic end products of exogenous metals or because they can be used, e.g., for refining a histochemical technique.
|
Acknowledgments |
|---|
This study was supported by The Danish Medical Research Council, Aarhus University Research Foundation, Danish Medical Association Research Fund, Aase & Ejnar Danielsens Fond, and the Lundbeck, Leo, Beckett, Gangsted, and Novo Nordic Foundations.
The authors gratefully acknowledge the skillful technical assistance of Ms D. Jensen, Mr A. Meier, Ms H. Mikkelsen, Mr T.A. Nielsen, Ms M. Sand, and Ms K. Wiedemann. We thank Søren Juhl for synthesizing the selenosulfate and commenting on the manuscript.
|
Footnotes |
|---|
Received for publication June 25, 2004; accepted September 30, 2004
|
Literature Cited |
|---|
|
TopSummaryIntroductionMaterials, Methods, and ResultsFuture Fields of Application...DiscussionLiterature Cited |
|---|
Barceloux DG (1999) Selenium. J Toxicol Clin Toxicol 37:145–172[CrossRef][Medline]
Birinyi A, Parker D, Antal M, Shupliakov O (2001) Zinc co-localizes with GABA and glycine in synapses in the lamprey spinal cord. J Comp Neurol 433:208–221[CrossRef][Medline]
Brown CE, Dyck RH (2003) An improved method for visualizing the cell bodies of zincergic neurons. J Neurosci Methods 129:41–47[CrossRef][Medline]
Castillo-Duran C, Cassorla F (1999) Trace minerals in human growth and development. J Pediatr Endocrinol Metab 12(suppl 2):589–601
Christensen MK (1995) Zinc-containing neurons in the rat amygdaloid complex. A retrograde tracing study. Thesis, Department of Neurobiology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark
Christensen MK, Frederickson CJ (1998) Zinc-containing afferent projections to the rat corticomedial amygdaloid complex: a retrograde tracing study. J Comp Neurol 400:375–390[CrossRef][Medline]
Christensen MK, Frederickson CJ, Danscher G (1992) Retrograde tracing of zinc-containing neurons by selenide ions: a survey of seven selenium compounds. J Histochem Cytochem 40:575–579[Abstract]
Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD (1999) Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci USA 96:1716–1721
Danscher G (1981) Histochemical demonstration of heavy metals. A revised version of the sulphide silver method suitable for both light and electronmicroscopy. Histochemistry 71:1–16[CrossRef][Medline]
Danscher G (1982) Exogenous selenium in the brain. A histochemical technique for light and electron microscopical localization of catalytic selenium bonds. Histochemistry 76:281–293[CrossRef][Medline]
Danscher G (1984a) Do the Timm sulphide silver method and the selenium method demonstrate zinc in the brain. In Frederickson CJ, Howell GA, Kasarkis E, eds. The Neurobiology of Zinc. Part A. New York, Alan R. Liss, 273–287
Danscher G (1984b) Dynamic changes in the stainability of rat hippocampal mossy fiber boutons after local injection of sodium sulphide, sodium selenite, and sodium diethyldithiocarbamate. In Frederickson CJ, Howell GA, Kasarkis E, eds. The Neurobiology of Zinc. Part B. New York, Alan R. Liss, 177–191
Danscher G (1984c) Similarities and differences in the localization of metals in rat brains after treatment with sodium sulphide and sodium selenide. In Frederickson CJ, Howell GA, Kasarkis E, eds. The Neurobiology of Zinc. Part A. New York, Alan R. Liss, 229–242
Danscher G (1994) Autometallographic (AMG) nerve tracing: demonstration of retrograde axonal transport of zinc selenide in zinc-enriched (ZEN) neurons. In Gu J, Hacker GW, eds. Modern Methods in Analytical Morphology. New York, Plenum Press, 327–339
Danscher G (1996) The autometallographic zinc-sulphide method. A new approach involving in vivo creation of nanometer-sized zinc sulphide crystal lattices in zinc-enriched synaptic and secretory vesicles. Histochem J 28:361–373[CrossRef][Medline]
Danscher G, Haug F-MS, Fredens K (1973) Effect of diethyldithiocarbamate (DEDTC) on sulphide silver stained boutons. Reversible blocking of Timm's sulphide silver stain for "heavy" metals in DEDTC treated rats (light microscopy). Exp Brain Res 16:521–532[Medline]
Danscher G, Howell G, Perez-Clausell J, Hertel N (1985b) The dithizone, Timm's sulphide silver and the selenium methods demonstrate a chelatable pool of zinc in CNS. A proton activation (PIXE) analysis of carbon tetrachloride extracts from rat brains and spinal cords intravitally treated with dithizone. Histochemistry 83:419–422[CrossRef][Medline]
Danscher G, Jo SM, Varea E, Wang Z, Cole TB, Schrøder HD (2001) Inhibitory zinc-enriched terminals in mouse spinal cord. Neuroscience 105:941–947[CrossRef][Medline]
Danscher G, Juhl S, Stoltenberg M, Krunderup B, Schrøder HD, Andreasen A (1997) Autometallographic silver enhancement of zinc sulfide crystals created in cryostat sections from human brain biopsies. A new technique that makes it feasible to demonstrate zinc ions in tissue sections from biopsies and early autopsy material. J Histochem Cytochem 45:1503–1510
Danscher G, Mosekilde L, Rungby J (1999) Histochemical detection of zinc in mineralizing rat bone: autometallographic tracing of zinc ions in the mineralization front, osteocytes, and osteoblasts. J Histotechnol 22:85–90
Danscher G, Stoltenberg M, Bruhn M, Søndergaard M, Jensen D (2004) Immersion autometallography: histochemical in situ capturing of zinc ions in catalytic zinc-sulphur nanocrystals. J Histochem Cytochem in press
Danscher G, Thorlacius-Ussing O, Rungby J, Møller-Madsen B (1985a) Selenium in the Paneth cells. Sci Total Environ 42:189–192[CrossRef][Medline]
Danscher G, Zimmer J (1978) An improved Timm sulphide silver method for light and electron microscopic localization of heavy metals in biological tissues. Histochemistry 55:27–40[CrossRef][Medline]
Derewenda U, Derewenda Z, Dodson GG, Hubbard RE, Korber F (1989) Molecular structure of insulin: the insulin monomer and its assembly. Br Med Bull 45:4–18
Dodson G, Steiner D (1998) The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol 8:189–194[CrossRef][Medline]
Frederickson CJ, Kasarskis EJ, Ringo D, Frederickson RE (1987b) A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J Neurosci Methods 20:91–103[CrossRef][Medline]
Frederickson CJ, Pérez-Clausell J, Danscher G (1987a) Zinc-containing 7S-NGF complex. Evidence from zinc histochemistry for localization in salivary secretory granules. J Histochem Cytochem 35:579–583[Abstract]
Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB (2000) Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130(suppl):1471–1483
Frost DV, Lish PM (1975) Selenium in biology. Annu Rev Pharmacol 15:259–284[CrossRef][Medline]
Hacker GW, Grimelius L, Danscher G, Bernatzky G, Muss W, Adam H, Thurner J (1988) Silver acetate autometallography. An alternative enhancement technique for immunogold-silver staining (IGSS) and silver amplification of gold, silver, mercury and zinc in tissues. J Histotechnol 11:213–221
Haug FM (1974) Light microscopical mapping of the hippocampal region, the pyriform cortex and the corticomedial amygdaloid nuclei of the rat with Timm's sulphide silver method. I. Area dentata, hippocampus and subiculum. Z Anat Entwicklungsgesch 145:1–27[CrossRef][Medline]
Hosie AM, Dunne EL, Harvey RJ, Smart TG (2003) Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity. Nat Neurosci 6:362–369[CrossRef][Medline]
Howell GA, Frederickson CJ (1990) A retrograde transport method for mapping zinc-containing fiber systems in the brain. Brain Res 515:277–286[CrossRef][Medline]
Howell GA, Frederickson CJ, Danscher G (1989) Evidence from dithizone and selenium zinc histochemistry that perivascular mossy fiber boutons stain preferentially "in vivo". Histochemistry 92:121–125[CrossRef][Medline]
Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB (2003) Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 5:330–335[CrossRef][Medline]
Jo SM, Danscher G, Schrøder HD, Won MH, Cole TB (2000b) Zinc-enriched (ZEN) terminals in mouse spinal cord: immunohistochemistry and autometallography. Brain Res 870:163–169[CrossRef][Medline]
Jo SM, Won MH, Cole TB, Jensen MS, Palmiter RD, Danscher G (2000a) Zinc enriched (ZEN) terminals in mouse olfactory bulb. Brain Res 865:227–236[CrossRef][Medline]
Kim BJ, Kim YH, Kim S, Kim JW, Koh JY, Oh SH, Lee MK, et al. (2000) Zinc as a paracrine effector in pancreatic islet cell death. Diabetes 49:367–372[Abstract]
Kristiansen LH, Rungby J, Søndergaard LG, Stoltenberg M, Danscher G (2001) Autometallography allows ultrastructural monitoring of zinc in the endocrine pancreas. Histochem Cell Biol 115:125–129[CrossRef][Medline]
Li Y, Hough CJ, Frederickson CJ, Sarvey JM (2001) Induction of mossy fiber Æ Ca3 long-term potentiation requires translocation of synaptically released Zn2+. J Neurosci 21:8015–8025
Liesegang RE (1911) Die Kolloidchemie der histologischen Silberfärbungen. In Ostwald W, ed. Kolloidchemische Beihefte (Ergänzungshefte zur Kolloid-Zeifschrift) Dresden–Leipzig, Verlag von Theodor Steinkopff, 1–44
Maiorino M, Flohe L, Roveri A, Steinert P, Wissing JB, Ursini F (1999) Selenium and reproduction. Biofactors 10:251–256[Medline]
Miro-Bernie N, Sancho-Bielsa FJ, Lopez-Garcia C, Pérez-Clausell J (2003) Retrograde transport of sodium selenite and intracellular injection of micro-ruby: a combined method to describe the morphology of zinc-rich neurones. J Neurosci Methods 127:199–209[CrossRef][Medline]
O'Toole D, Castle LE, Raisbeck MF (1995) Comparison of histochemical autometallography (Danscher's stain) to chemical analysis for detection of selenium in tissues. Vet Diagn Invest 7:281–284
Palmiter RD, Cole TB, Quaife CJ, Findley SD (1996) ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A 93:14934–14939
Pérez-Clausell J, Danscher G (1986) Release of zinc sulphide accumulations into synaptic clefts after in vivo injection of sodium sulphide. Brain Res 362:358–361[CrossRef][Medline]
Rayman MP, Rayman MP (2002) The argument for increasing selenium intake. Proc Nutr Soc 61:203–215[CrossRef][Medline]
Rubio ME, Juiz JM (1998) Chemical anatomy of excitatory endings in the dorsal cochlear nucleus of the rat: differential synaptic distribution of aspartate aminotransferase, glutamate, and vesicular zinc. J Comp Neurol 399:341–358[CrossRef][Medline]
Schrøder HD, Danscher G, Jo SM, Su H (2000) Zinc-enriched boutons in rat spinal cord. Brain Res 868:119–122[CrossRef][Medline]
Sensi SL, Yin HZ, Weiss JH (1999) Glutamate triggers preferential Zn2+ flux through Ca2+ permeable AMPA channels and consequent ROS production. Neuroreport 10:1723–1727[Medline]
Slomianka L (1992) Neurons of origin of zinc-containing pathways and the distribution of zinc-containing boutons in the hippocampal region of the rat. Neuroscience 48:325–352[CrossRef][Medline]
Slomianka L, Edelfors S, Ravn-Jensen A, Rungby J, Danscher G, West MJ (1990) The effect of low-level toluene exposure on the developing hippocampal region of the rat: histological evidence and volumetric findings. Toxicology 62:189–202[CrossRef][Medline]
Stierhof YD, Humbel BM, Schwarz H (1991) Suitability of different silver enhancement methods applied to 1 nm colloidal gold particles: an immunoelectron microscopic study. J Electron Microsc Tech 17:336–343[CrossRef][Medline]
Stoltenberg M, Danscher G (2000) Histochemical differentiation of autometallographically traceable metals (Au, Ag, Hg, Bi, Zn): protocols for chemical removal of separate autometallographic metal clusters in Epon sections. Histochem J 32:645–652[CrossRef][Medline]
Stoltenberg M, Ernst E, Andreasen A, Danscher G (1996) Histochemical localization of zinc ions in the epididymis of the rat. Histochem J 28:173–185[CrossRef][Medline]
Stoltenberg M, Lund L, Juhl S, Danscher G, Ernst E (1997) Histochemical demonstration of zinc ions in human epididymis using autometallography. Histochem J 29:721–726[CrossRef][Medline]
Søndergaard LG, Stoltenberg M, Flyvbjerg A, Brock B, Schmitz O, Danscher G, Rungby J (2003) Zinc ions in ß-cells of obese, insulin-resistant, and type 2 diabetic rats traced by autometallography. APMIS 111:1147–1154[CrossRef][Medline]
Sørensen MB, Stoltenberg M, Henriksen K, Ernst E, Danscher G, Parvinen M (1998) Histochemical tracing of zinc ions in the rat testis. Mol Hum Reprod 4:423–428
Sørensen MB, Stoltenberg M, Juhl S, Danscher G, Ernst E (1997) Ultrastructural localization of zinc ions in the rat prostate: an autometallographic study. Prostate 31:125–130[CrossRef][Medline]
Thorlacius-Ussing O, Danscher G, Møller-Madsen B, Rungby J (1985) Selenium in the anterior pituitary. Sci Total Environ 42:185–188[CrossRef][Medline]
Timm F (1958) Zur Histochemie der Schwermetalle. Das Sulfid-Silberverfahren. Dtsch Z Gerichtl Med 46:706–711
Wang Z, Danscher G, Jo SM, Shi Y, Schrøder HD (2001a) Retrograde tracing of zinc-enriched (ZEN) neuronal somata in rat spinal cord. Brain Res 900:80–87[CrossRef][Medline]
Wang Z, Danscher G, Kim YK, Dahlström A, Jo SM (2002b) Inhibitory zinc-enriched terminals in the mouse cerebellum: double-immunohistochemistry for zinc transporter 3 and glutamate decarboxylase. Neurosci Lett 321:37–40[CrossRef][Medline]
Wang Z, Li J-Y, Dahlström A, Danscher G (2001b) Zinc-enriched GABAergic terminals in mouse spinal cord. Brain Res 921:165–172[CrossRef][Medline]
Wang ZY, Danscher G, Dahlström A, Li JY (2003) Zinc transporter 3 and zinc ions in the rodent superior cervical ganglion neurons. Neuroscience 120:605–616[CrossRef][Medline]
Wang ZY, Li J-Y, Danscher G, Dahlström A (2002a) Localization of zinc-enriched neurons in the mouse peripheral sympathetic system. Brain Res 928:165–174[CrossRef][Medline]
Weiss JH, Sensi SL, Koh JY (2000) Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 21:395–401[CrossRef][Medline]
Wilber CG (1980) Toxicology of selenium: a review. Clin Toxicol 17:171–230[Medline]
Zalewski PD, Forbes IJ, Betts WH (1993) Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 296:403–408
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. J. Hwang, S.-J. Lee, T.-Y. Kim, J.-H. Cho, and J.-Y. Koh Zinc and 4-Hydroxy-2-Nonenal Mediate Lysosomal Membrane Permeabilization Induced by H2O2 in Cultured Hippocampal Neurons J. Neurosci., March 19, 2008; 28(12): 3114 - 3122. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||